鞍鋼股份(00347.HK)與鞍鋼北京研究院訂立2020年技術開發協議
鞍鋼股份(00347.HK)公布關連交易,與鞍鋼北京研究院訂立2020年技術開發協議,以為公司合作研發若干技術。
公司指,鞍鋼北京研究院是鞍鋼集團公司下屬的具有前瞻性的技術研發平台,具有較高的科研定位,在鋼鐵材料技術研究、新材料計算設計、工藝模擬技術等領域具有較強的科研實力。上述項目研發成功將有助於提升公司基礎研發水平,使公司保持目前造船用鋼等領域的領先水平,拓展自身在新能源汽車、耐蝕降噪鐵基阻尼合金以及針狀焦粉製備鋰電矽碳負極材料等新材料領域的引領能力,從而為公司提升科技研發能力、產品競爭力和未來盈利能力提供強有力支撐。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.